Martine Rothblatt
2010
In 2010, Martine Rothblatt earned a total compensation of $17.6M as Chief Executive Officer at United Therapeutics, which was about the same as previous year.
Compensation breakdown
| Change in Pension Value and Nonqualified Deferred Compensation Earnings | $1,526,156 |
|---|---|
| Non-Equity Incentive Plan | $900,000 |
| Option Awards | $14,263,681 |
| Salary | $874,768 |
| Other | $56,203 |
| Total | $17,620,808 |
Rothblatt received $14.3M in option awards, accounting for 81% of the total pay in 2010.
Rothblatt also received $1.5M of change in pension value and nonqualified deferred compensation earnings, $900K in non-equity incentive plan, $874.8K in salary and $56.2K in other compensation.
Rankings
In 2010, Martine Rothblatt's compensation ranked 105th out of 10,439 executives tracked by ExecPay. In other words, Rothblatt earned more than 99.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 105 out of 10,439 | 99th |
Division Manufacturing | 36 out of 3,838 | 99th |
Major group Chemicals And Allied Products | 6 out of 921 | 99th |
Industry group Drugs | 5 out of 680 | 99th |
Industry Pharmaceutical Preparations | 4 out of 481 | 99th |
Source: SEC filing on April 30, 2012.
Rothblatt's colleagues
We found three more compensation records of executives who worked with Martine Rothblatt at United Therapeutics in 2010.